We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

22 hedge funds and large institutions have $2.61M invested in Albireo Pharma Inc in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more capital invested

Capital invested by funds: $1.77M → $2.61M (+$842K)

8% less funds holding

Funds holding: 24 → 22 (-2)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
5
Closed
5
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$13K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$148K
2
BFA
BlackRock Fund Advisors
California
+$45.4K
3
PAM
Panagora Asset Management
Massachusetts
+$42.7K
4
UBS Group
UBS Group
Switzerland
+$10.8K
5
TSS
Two Sigma Securities
New York
+$5.8K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$53K
2
VKH
Virtu KCG Holdings
New York
-$22.2K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$12K
4
Citadel Advisors
Citadel Advisors
Florida
-$10.6K
5
Group One Trading
Group One Trading
Illinois
-$4.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.7M +$148K +12,518 +11%
Vanguard Group
2
Vanguard Group
Pennsylvania
$602K -$53K -4,496 -9%
BFA
3
BlackRock Fund Advisors
California
$55K +$45.4K +3,853 +1,033%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$50K – – –
PAM
5
Panagora Asset Management
Massachusetts
$47K +$42.7K +3,622 New
PVH
6
Psagot Value Holdings
Israel
$31K – – –
Group One Trading
7
Group One Trading
Illinois
$22K -$4.04K -343 -17%
Citadel Advisors
8
Citadel Advisors
Florida
$20K -$10.6K -900 -36%
Northern Trust
9
Northern Trust
Illinois
$20K – – –
UBS Group
10
UBS Group
Switzerland
$12K +$10.8K +918 +7,650%
BIT
11
BlackRock Institutional Trust
California
$11K – – –
CG
12
Cutler Group
California
$11K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$10K – – –
Goldman Sachs
14
Goldman Sachs
New York
$7K -$35 -3 -0.5%
TSS
15
Two Sigma Securities
New York
$6K +$5.8K +492 New
VKH
16
Virtu KCG Holdings
New York
$5K -$22.2K -1,885 -82%
PMFA
17
Plante Moran Financial Advisors
Michigan
$1K – – –
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
– -$12K -1,246 Closed
Ameriprise
19
Ameriprise
Minnesota
– -$4K -410 Closed
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
– -$3K -372 Closed
FNBT
21
FineMark National Bank & Trust
Florida
– -$2K -243 Closed
Wells Fargo
22
Wells Fargo
California
– +$94 +8 New
Bank of America
23
Bank of America
North Carolina
– +$212 +18 +72%

ALBO Hedge Fund Activity: Q3 2016 in Review

22 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2016, worth a combined $2.61M — up 48% from $1.77M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ALBO and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $148K. The largest seller was Vanguard Group, cutting an estimated $53K.

  • 22 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2016, down from 24 in Q2 2016.
  • Funds reported $2.61M of Albireo Pharma Inc stock for Q3 2016, up 48% quarter-over-quarter.
  • 3 funds opened new Albireo Pharma Inc positions in Q3 2016 and 5 closed out, a net change of -2 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2016 was Renaissance Technologies, an estimated $148K added.
  • The largest Albireo Pharma Inc seller in Q3 2016 was Vanguard Group, an estimated $53K sold.

Based on aggregated 13F filings for Q3 2016.